Physician profile
Derek A Haas
NPI 1447336664
$2,725.55
in general payments reported to CMS, 2019-2025
10 companies · $312 in 2025
The $312 reported for 2025 was more than what 78% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $427 · 2021: $434 · 2022: $451 · 2023: $591 · 2024: $136 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,415.79 | 2019-2025 | Menopur |
| Emd Serono, INC. | $785.46 | 2019-2025 | |
| Abbvie INC. | $171.82 | 2020-2021 | |
| Minerva Surgical, INC | $132.65 | 2021-2024 | |
| Coopersurgical, INC. | $76.77 | 2025 | Stripper |
| Myovant Sciences INC. | $43.29 | 2021-2022 | |
| Galen US INC | $41.62 | 2019-2021 | |
| Meditrina | $21.25 | 2022-2025 | |
| Vertical Pharmaceuticals, LLC | $18.86 | 2019 | |
| Shield Therapeutics INC | $18.04 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.